Kinetics and Mechanism of Interaction of cis-Diaquabis(oxalato)chromate(III) with Cefoperazone in Aqueous Medium: as an Antibacterial Study

[1] Vincent JB(2001)The bioinorganic chemistry of chromium (III) Polyhedron 20 1-26

[2] Yamamoto A(1987)Isolation of a biologically active low-molecular-mass chromium compound from rabbit liver Eur J Biochem 165 627-631

[3] Wada O(2005)New chromium(III)-nicotinate complexes. Kinetics and mechanism of nicotinate ligand liberation in acidic media Transit Met Chem 30 623-629

[4] Ono T(2017)Drug metal ion interaction: kinetics and mechanism of interaction of cis-bis (oxalate)diaquochromium(III) ion with ampicillin in aqueous medium Chem Sci Trans 6 535-544

[5] Szablowicz M(2011)Kinetics and mechanism of interaction of hexaaquachromium (III) with L-dopa in aqueous medium: comparative antiparkinsonian studies Transit Met Chem 36 231-236

[6] Kita E(2010)Kinetics and mechanisms of the chromium(III) reactions with 2,4- and 2,5-dihydroxybenzoic acids in weak acidic aqueous solutions Bioinorg Chem Appl 2010 1-10

[7] Behera B(2008)Kinetics and mechanism of the reaction between chromium(III) and 3,4-dihydroxy-phenyl-propenoic acid (caffeic acid) in weak acidic aqueous solutions Bioinorg Chem Appl 2008 1-7

[8] Behera J(2013)Kinetics and mechanism of interaction between chromium(III) and ethylenediaminetetra-3-propinate in aqueous acidic media Adv Chem Eng Sci 3 98-104

[9] Baral D(1976)Copper chelates as possible active forms of the antiarthritic agents J Med Chem 19 135-141

[10] Rout S(1980)Antiinflammatory effects of some copper complexes J Med Chem 23 729-733

[1] Vincent JB(2001)The bioinorganic chemistry of chromium (III) Polyhedron 20 1-26

[2] Yamamoto A(1987)Isolation of a biologically active low-molecular-mass chromium compound from rabbit liver Eur J Biochem 165 627-631

[3] Wada O(2005)New chromium(III)-nicotinate complexes. Kinetics and mechanism of nicotinate ligand liberation in acidic media Transit Met Chem 30 623-629

[4] Ono T(2017)Drug metal ion interaction: kinetics and mechanism of interaction of cis-bis (oxalate)diaquochromium(III) ion with ampicillin in aqueous medium Chem Sci Trans 6 535-544

[5] Szablowicz M(2011)Kinetics and mechanism of interaction of hexaaquachromium (III) with L-dopa in aqueous medium: comparative antiparkinsonian studies Transit Met Chem 36 231-236

[6] Kita E(2010)Kinetics and mechanisms of the chromium(III) reactions with 2,4- and 2,5-dihydroxybenzoic acids in weak acidic aqueous solutions Bioinorg Chem Appl 2010 1-10

[7] Behera B(2008)Kinetics and mechanism of the reaction between chromium(III) and 3,4-dihydroxy-phenyl-propenoic acid (caffeic acid) in weak acidic aqueous solutions Bioinorg Chem Appl 2008 1-7

[8] Behera J(2013)Kinetics and mechanism of interaction between chromium(III) and ethylenediaminetetra-3-propinate in aqueous acidic media Adv Chem Eng Sci 3 98-104

[9] Baral D(1976)Copper chelates as possible active forms of the antiarthritic agents J Med Chem 19 135-141

[10] Rout S(1980)Antiinflammatory effects of some copper complexes J Med Chem 23 729-733